ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2169

Temporal Trends in Mortality in Patients Hospitalized for Cerebrovascular Events with Psoriatic Arthritis: Data from the Healthcare Cost and Utilization Project from 2010-2014

Shraddha Jatwani1, Karan Chugh2, Karan Jatwani3, Stuthi Perimbeti4, Vivek Modi5, Jasleen Kaur6 and Rakesh K Sharma7, 1Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI, 2Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, 3Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, 4Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, NEW YORK, NY, 5Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, New York, NY, 6Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, 7Department of Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cerebrovascular disease, Morbidity and mortality and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Epidemiology and Public Health Poster III: SLE, SSc, APS, PsA, and Other Rheumatic Diseases

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Cerebrovascular disease risk in increased in patients of Psoriatic arthritis (PsA), as reported in the literature. Epidemiological studies to assesses average annual trends are not available in current literature. Majority of studies are from single centers. Our objectives were to describe the demographics and trends of outcomes for PsA patients admitted with cerebrovascular events in United States.

Methods:

We analyzed data from the Healthcare Cost and Utilization Project’s (HCUP) National Inpatient Sample (NIS). All hospitalized adult (>18 years) patients between 2010 and 2014 hospitalized for cerebrovascular event (stroke or transient ischemic attack) from NIS database were captured, and stratified into two groups based on secondary diagnosis of PsA, using ICD9 codes. Stata version 15 (College Station, TX) was used to perform the statistical analysis. We analyzed the trends in hospitalization, length of stay, total cost per admission and mortality for cerebrovascular events. Chi-Square test, linear regression and multivariate regression models were used for analysis.

Results:

Between 2010 and 2014, 2,255,127 were hospitalized with cerebrovascular events including acute stroke and transient ischemic attack (TIA). 1583 patients were found to have a secondary diagnosis of PsA. Patients admitted with cerebrovascular events and underlying PSA had a mean age of 67.5 ±0.71 years, which was significantly lower in comparison to general population where mean age was 70.86 ±0.08 years (p value = 0.00). 50.49% patients were females in patients with PsA. There was no significant difference in rates of overall mortality between the two groups from 2010-2014 (2.99% for patients without PsA and 2.71% for patients with PsA, p value=0.769), and this trend was noted in mortality rates from each year (2010 to 2014).

Conclusion:

Patients with PsA were admitted with cerebrovascular events at a younger age compared to their counterparts, suggesting higher burden of comorbidities and inflammation. Compared to previously reported data, there wasn’t a significance difference in cerebrovascular mortality in patients with PsA. Decreased risk of mortality possibly reflects early recognition and treatment of PsA, with increased awareness of PsA as well as associated cardiovascular risk. Providers should continue to screen patients with PsA for risk factors associated with cardiovascular and cerebrovascular morbidity and mortality, to improve healthcare outcomes.


Disclosure: S. Jatwani, None; K. Chugh, None; K. Jatwani, None; S. Perimbeti, None; V. Modi, None; J. Kaur, None; R. K. Sharma, None.

To cite this abstract in AMA style:

Jatwani S, Chugh K, Jatwani K, Perimbeti S, Modi V, Kaur J, Sharma RK. Temporal Trends in Mortality in Patients Hospitalized for Cerebrovascular Events with Psoriatic Arthritis: Data from the Healthcare Cost and Utilization Project from 2010-2014 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/temporal-trends-in-mortality-in-patients-hospitalized-for-cerebrovascular-events-with-psoriatic-arthritis-data-from-the-healthcare-cost-and-utilization-project-from-2010-2014/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/temporal-trends-in-mortality-in-patients-hospitalized-for-cerebrovascular-events-with-psoriatic-arthritis-data-from-the-healthcare-cost-and-utilization-project-from-2010-2014/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology